Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 13

Long-term safety of tiotropium/olodaterol Respimat® in patients with moderate-to-very severe COPD and renal impairment in the TONADO® studies

Total article views   Abstract views HTML views PDF downloads Totals
8,060 Dovepress* 5,578 1,318+ 1,409 6,896
PubMed Central* 0 1,164 210 1,164
Totals 5,578 2,482 1,619 8,060
*Since 1 June 2018
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
14 0 0 0 6 8

View citations on PubMed Central and Google Scholar